These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6127907)

  • 21. Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.
    Wallis TD; Vallé-Jones JC; Craven JR; Hanks GW; Stonier PD
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):123S-127S. PubMed ID: 35192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial of halazepam and clorazepate: considerations of a single bedtime dose [proceedings].
    Cohen NL; Alpert M; Friedhoff AJ
    Psychopharmacol Bull; 1981 Jan; 17(1):134-5. PubMed ID: 6112774
    [No Abstract]   [Full Text] [Related]  

  • 23. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1988 May; 49(5):189-92. PubMed ID: 2896666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of a single night-time dose of potassium clorazepate in anxiety: a controlled trial comparison with diazepam.
    Henderson JG
    Scott Med J; 1982 Oct; 27(4):292-6. PubMed ID: 6128788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative anxiolysis with minimal sedation in elderly patients: bromazepam or clorazepate-dipotassium?
    Erb T; Sluga M; Hampl KF; Ummenhofer W; Schneider MC
    Acta Anaesthesiol Scand; 1998 Jan; 42(1):97-101. PubMed ID: 9527752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cloxazolam in dermatology. Double-blind study against dipotassium clorazepate].
    Desmons F; Bergoend H; Thomas P; Piette F
    Lille Med; 1980; 25(1-2):45-8. PubMed ID: 6103494
    [No Abstract]   [Full Text] [Related]  

  • 27. Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect?
    Rickels K; Case WG; Downing RW; Winokur A
    Adv Biochem Psychopharmacol; 1985; 40():193-204. PubMed ID: 3895840
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of clorazepate (Tranxene) as an anticonvulsant--a pilot study.
    Troupin AS; Friel P; Wilensky AJ; Morretti-Ojemann L; Levy RH; Feigl P
    Neurology; 1979 Apr; 29(4):458-66. PubMed ID: 35767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clorazepate in the management of coronary disease.
    Wheatley D
    Psychosomatics; 1979 Mar; 20(3):195, 198-9, 203-5. PubMed ID: 35810
    [No Abstract]   [Full Text] [Related]  

  • 30. Buspirone in the treatment of panic disorder: a controlled pilot comparison with clorazepate.
    Schweizer E; Rickels K
    J Clin Psychopharmacol; 1988 Aug; 8(4):303. PubMed ID: 2905363
    [No Abstract]   [Full Text] [Related]  

  • 31. Attenuation of drug-induced anxiety dreams and pavor nocturnus by benzodiazepines.
    Allen RM
    J Clin Psychiatry; 1983 Mar; 44(3):106-8. PubMed ID: 6131884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study.
    Wilensky AJ; Ojemann LM; Temkin NR; Troupin AS; Dodrill CB
    Neurology; 1981 Oct; 31(10):1271-6. PubMed ID: 6125918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepines and neurotic anxiety. Critique.
    Solomon K
    N Y State J Med; 1976 Dec; 76(13):2156-64. PubMed ID: 11427
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tranxillium 20 (dipotassium chlorazepate) as a 24-hr tranquilizer].
    Skupin G; Franzke HG
    Med Welt; 1975 May; 26(19):956-9. PubMed ID: 237172
    [No Abstract]   [Full Text] [Related]  

  • 35. Lorazepam and diazepam in the treatment of neurotic anxiety: a double-blind trial.
    Valarino F; Perez-Lopez R
    Dis Nerv Syst; 1976 Feb; 37(2):58-61. PubMed ID: 1213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lorazepam and diazepam in the treatment of benign paroxysmal vertigo.
    McClure JA; Willett JM
    J Otolaryngol; 1980 Dec; 9(6):472-7. PubMed ID: 6110782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The side effect profile of buspirone in comparison to active controls and placebo.
    Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind study of lorazepam and diazepam in status epilepticus.
    Leppik IE; Derivan AT; Homan RW; Walker J; Ramsay RE; Patrick B
    JAMA; 1983 Mar; 249(11):1452-4. PubMed ID: 6131148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of buspirone in two separate studies.
    Goldberg HL; Finnerty R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):87-91. PubMed ID: 6759499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.